The first study of dabrafenib in pediatric patients with BRAF V600-mutant relapsed or refractory low-grade gliomas

被引：20

作者：

Kieran, M. W. ^{[1
]}

Bouffet, E. ^{[2
]}

Tabori, U. ^{[3
]}

Broniscer, A. ^{[4
]}

Cohen, K. ^{[5
]}

Hansford, J. ^{[6
]}

Geoerger, B. ^{[7
]}

Hingorani, P. ^{[8
]}

Dunkel, I. ^{[9
]}

Russo, M. ^{[10
]}

Tseng, L. ^{[10
]}

Liu, Q. ^{[10
]}

Nebot, N. ^{[10
]}

Whitlock, J. ^{[2
]}

Hargrave, D. ^{[11
]}

机构：

[1] Harvard Med Sch, Boston Childrens Hosp, Pediat Med Neurooncol, Dana Farber Canc Inst, Boston, MA USA

[2] Univ Toronto, Hosp Sick Children, Haematol Oncol, Toronto, ON, Canada

[3] Univ Toronto, Hosp Sick Children, Div Haematol Oncol, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON, Canada

[4] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA

[5] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Pediat Oncol, Baltimore, MD USA

[6] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Childrens Canc Ctr, Melbourne, Vic, Australia

[7] Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France

[8] Phoenix Childrens Hosp, Hematol Oncol, Phoenix, AZ USA

[9] Mem Sloan Kettering Canc Ctr, Pediat Oncol, 1275 York Ave, New York, NY 10021 USA

[10] Novartis Pharmaceut, Global Oncol, E Hanover, NJ USA

[11] Great Ormond St Hosp Sick Children, Haematol & Oncol, London, England

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

10.1093/annonc/mdw435.9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA19_PR

引用

页数：1

共 50 条

[1] Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600-mutant relapsed refractory low-grade glioma.
Kieran, Mark W.
Bouffet, Eric
Broniscer, Alberto
Cohen, Kenneth J.
Geoerger, Birgit
Hansford, Jordan R.
Hingorani, Pooja
Aerts, Isabelle
Andre, Nicolas
Bertozzi-Salamon, Anne-Isabelle
Dunkel, Ira J.
Hummel, Trent Ryan
Leary, Sarah
Moreno, Lucas
Russo, Mark W.
Tseng, Lillian
Dasgupta, Kohinoor
Nebot, Noelia
Whitlock, James
Hargrave, Darren R.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[2] Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade Glioma
Bouffet, Eric
Geoerger, Birgit
Moertel, Christopher
Whitlock, James A.
Aerts, Isabelle
Hargrave, Darren
Osterloh, Lisa
Tan, Eugene
Choi, Jeea
Russo, Mark
Fox, Elizabeth
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 664 - +
[3] Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma
Hargrave, Darren R.
Terashima, Keita
Hara, Junichi
Kordes, Uwe R.
Upadhyaya, Santhosh A.
Sahm, Felix
Bouffet, Eric
Packer, Roger J.
Witt, Olaf
Sandalic, Larissa
Kieloch, Agnieszka
Russo, Mark
Cohen, Kenneth J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (33) : 5174 - +
[4] Dabrafenib plus trametinib combination therapy in pediatric patients with BRAF V600-mutant low-grade glioma: Safety and efficacy results.
Geoerger, Birgit
Bouffet, Eric
Whitlock, James A.
Moertel, Christopher L.
Hargrave, Darren R.
Aerts, Isabelle
Cohen, Kenneth J.
Kilburn, Lindsay Baker
Wright, Karen D.
Choi, Jeea
Gasal, Eduard
Russo, Mark W.
Fox, Elizabeth
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[5] A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation
Cheng-Ying Ho
Bret C. Mobley
Heather Gordish-Dressman
Christopher J. VandenBussche
Gary E. Mason
Miriam Bornhorst
Adam J. Esbenshade
Mahtab Tehrani
Brent A. Orr
Delecia R. LaFrance
Joseph M. Devaney
Beatrix W. Meltzer
Sean E. Hofherr
Peter C. Burger
Roger J. Packer
Fausto J. Rodriguez
[J]. Acta Neuropathologica, 2015, 130 : 575 - 585
[6] A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation
Ho, Cheng-Ying
Mobley, Bret C.
Gordish-Dressman, Heather
VandenBussche, Christopher J.
Mason, Gary E.
Bornhorst, Miriam
Esbenshade, Adam J.
Tehrani, Mahtab
Orr, Brent A.
LaFrance, Delecia R.
Devaney, Joseph M.
Meltzer, Beatrix W.
Hofherr, Sean E.
Burger, Peter C.
Packer, Roger J.
Rodriguez, Fausto J.
[J]. ACTA NEUROPATHOLOGICA, 2015, 130 (04) : 575 - 585
[7] Phase II open-label, global study evaluating dabrafenib in combination with trametinib in pediatric patients with BRAF V600-mutant high-grade glioma (HGG) or low-grade glioma (LGG)
Hargrave, D.
Witt, O.
Cohen, K.
Packer, R.
Lissat, A.
Kordes, U.
Laetsch, T. W.
Hoffman, L.
Lassaletta, A.
Gerber, N. U.
Gilheeney, S.
Holm, S.
Kramm, C.
Sumerauer, D.
Reitmann, C.
Russo, M. W.
Bouffet, E.
[J]. ANNALS OF ONCOLOGY, 2018, 29 : 132 - 132
[8] Evaluation of the effect of dabrafenib on QTc interval in patients with BRAF V600-mutant tumors
Nebot, Noelia
Arkenau, Ht
Infante, Jeffrey R.
Chandler, Jason Claud
Weickhardt, Andrew
Lickliter, Jason D.
Sarantopoulos, John
Gordon, Michael S.
St-Pierre, Annie
Tang, Lihua
Mookerjee, Bijoyesh
Carson, Stanley W.
Grossmann, Kenneth F.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[9] Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study
Hargrave, Darren R.
Bouffet, Eric
Tabori, Uri
Broniscer, Alberto
Cohen, Kenneth J.
Hansford, Jordan R.
Geoerger, Birgit
Hingorani, Pooja
Dunkel, Ira J.
Russo, Mark W.
Tseng, Lillian
Dasgupta, Kohinoor
Gasal, Eduard
Whitlock, James A.
Kieran, Mark W.
[J]. CLINICAL CANCER RESEARCH, 2019, 25 (24) : 7303 - 7311
[10] SAFETY AND EFFICACY OF TRAMETINIB (T) MONOTHERAPY AND DABRAFENIB plus TRAMETINIB (D plus T) COMBINATION THERAPY IN PEDIATRIC PATIENTS WITH BRAF V600-MUTANT LOW-GRADE GLIOMA (LGG)
Bouffet, Eric
Whitlock, James A.
Moertel, Christopher
Geoerger, Birgit
Aerts, Isabelle
Hargrave, Darren
Cohen, Kenneth J.
Kilburn, Lindsay B.
Upadhyaya, Santhosh A.
Wetmore, Cynthia
Wright, Karen D.
Choi, Jeea
Gasal, Eduard
Russo, Mark W.
Fox, Elizabeth
[J]. NEURO-ONCOLOGY, 2020, 22 : 375 - 375

← 1 2 3 4 5 →